Rosamaria Capuano

Dr. Rosamaria Capuano

1. Department of Electronic Engineering, University of Rome Tor Vergata, Roma, Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Analytica Chimica Acta
Verified
Journal Article
Closed access
Corrado Di NataleCorrado Di Natale
Corrado Di Natale
Roberto PaolesseRoberto Paolesse
Roberto Paolesse
EMEugenio Martinelli
Eugenio Martinelli
RCRosamaria Capuano
Rosamaria Capuano

1 April 2010 in Chest
Verified
Journal Article
Closed access
PDF file
PMPaolo Montuschi
Paolo Montuschi
Marco SantonicoMarco Santonico
Marco Santonico
CMChiara Mondino
Chiara Mondino
Giorgio PennazzaGiorgio Pennazza
Giorgio Pennazza
GMGiulia Mantini
Giulia Mantini
ADArnaldo D'AMico
Arnaldo D'AMico

12 November 2015 in Scientific Reports
Verified
Journal Article
Open access
RCRosamaria Capuano
Rosamaria Capuano
Marco SantonicoMarco Santonico
Marco Santonico
GPGiorgio Pennazza
Giorgio Pennazza
SGSilvia Ghezzi
Silvia Ghezzi
EMEugenio Martinelli
Eugenio Martinelli
ADArnaldo D’aMico
Arnaldo D’aMico
Results collected in more than 20 years of studies suggest a relationship between the volatile organic compounds exhaled in breath and lung cancer. However, the origin of these compounds is still not completely elucidated. In spite of the simplistic vision that cancerous tissues in lungs directly emit the volatile metabolites into the airways, some papers point out that metabolites are collected by the blood and then exchanged at the air-blood interface in the lung. To shed light on this subject we performed an experiment collecting both the breath and the air inside both the lungs with a modified bronchoscopic probe. The samples were measured with a gas chromatography-mass spectrometer (GC-MS) and an electronic nose. We found that the diagnostic capability of the electronic nose does not depend on the presence of cancer in the sampled lung, reaching in both cases an above 90% correct classification rate between cancer and non-cancer samples. On the other hand, multivariate analysis of GC-MS achieved a correct classification rate between the two lungs of only 76%. GC-MS analysis of breath and air sampled from the lungs demonstrates a substantial preservation of the VOCs pattern from inside the lung to the exhaled breath.

6 January 2014 in Scientific Reports
Verified
Journal Article
Open access
MSMartin Strauch
Martin Strauch
ALAlja Lüdke
Alja Lüdke
DMDaniel Münch
Daniel Münch
TLThomas Laudes
Thomas Laudes
CGC. Giovanni Galizia
C. Giovanni Galizia
Corrado Di NataleCorrado Di Natale
Corrado Di Natale
Cancer cells and non-cancer cells differ in their metabolism and they emit distinct volatile compound profiles, allowing to recognise cancer cells by their scent. Insect odorant receptors are excellent chemosensors with high sensitivity and a broad receptive range unmatched by current gas sensors. We thus investigated the potential of utilising the fruit fly's olfactory system to detect cancer cells. Using in vivo calcium imaging, we recorded an array of olfactory receptor neurons on the fruit fly's antenna. We performed multidimensional analysis of antenna responses, finding that cell volatiles from different cell types lead to characteristic response vectors. The distances between these response vectors are conserved across flies and can be used to discriminate healthy mammary epithelial cells from different types of breast cancer cells. This may expand the repertoire of clinical diagnostics, and it is the first step towards electronic noses equipped with biological sensors, integrating artificial and biological olfaction.

25 August 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LLLuca Lavra
Luca Lavra
ACAlexandro Catini
Alexandro Catini
AUAlessandra Ulivieri
Alessandra Ulivieri
RCRosamaria Capuano
Rosamaria Capuano
LSLeila Baghernajad Salehi
Leila Baghernajad Salehi
Corrado Di NataleCorrado Di Natale
Corrado Di Natale
The efficacy of breath volatile organic compounds (VOCs) analysis for the screening of patients bearing breast cancer lesions has been demonstrated by using gas chromatography and artificial olfactory systems. On the other hand,in-vitrostudies suggest that VOCs detection could also give important indications regarding molecular and tumorigenic characteristics of tumor cells. Aim of this study was to analyze VOCs in the headspace of breast cancer cell lines in order to ascertain the potentiality of VOCs signatures in giving information about these cells and set-up a new sensor system able to detect breast tumor-associated VOCs. We identified by Gas Chromatography-Mass Spectrometry analysis a VOCs signature that discriminates breast cancer cells for: i) transformed condition; ii) cell doubling time (CDT); iii) Estrogen and Progesterone Receptors (ER, PgR) expression and HER2 overexpression. Moreover, the signals obtained from a temperature modulated metal oxide semiconductor gas sensor can be classified in order to recognize VOCs signatures associated with breast cancer cells, CDT and ER expression. Our results demonstrate that VOCs analysis could give clinically relevant information about proliferative and molecular features of breast cancer cells and pose the basis for the optimization of a low-cost diagnostic device to be used for tumors characterization.

29 March 2016 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
GSGiuseppe Santini
Giuseppe Santini
NMNadia Mores
Nadia Mores
APAndreu Penas
Andreu Penas
RCRosamaria Capuano
Rosamaria Capuano
CMChiara Mondino
Chiara Mondino
PMPaolo Montuschi
Paolo Montuschi
Breathomics, the multidimensional molecular analysis of exhaled breath, includes analysis of exhaled breath with gas-chromatography/mass spectrometry (GC/MS) and electronic noses (e-noses), and metabolomics of exhaled breath condensate (EBC), a non-invasive technique which provides information on the composition of airway lining fluid, generally by high-resolution nuclear magnetic resonance (NMR) spectroscopy or MS methods. Metabolomics is the identification and quantification of small molecular weight metabolites in a biofluid. Specific profiles of volatile compounds in exhaled breath and metabolites in EBC (breathprints) are potentially useful surrogate markers of inflammatory respiratory diseases. Electronic noses (e-noses) are artificial sensor systems, usually consisting of chemical cross-reactive sensor arrays for characterization of patterns of breath volatile compounds, and algorithms for breathprints classification. E-noses are handheld, portable, and provide real-time data. E-nose breathprints can reflect respiratory inflammation. E-noses and NMR-based metabolomics of EBC can distinguish patients with respiratory diseases such as asthma, COPD, and lung cancer, or diseases with a clinically relevant respiratory component including cystic fibrosis and primary ciliary dyskinesia, and healthy individuals. Breathomics has also been reported to identify patients affected by different types of respiratory diseases. Patterns of breath volatile compounds detected by e-nose and EBC metabolic profiles have been associated with asthma phenotypes. In combination with other -omics platforms, breathomics might provide a molecular approach to respiratory disease phenotyping and a molecular basis to tailored pharmacotherapeutic strategies. Breathomics might also contribute to identify new surrogate markers of respiratory inflammation, thus, facilitating drug discovery. Validation in newly recruited, prospective independent cohorts is essential for development of e-nose and EBC NMRbased metabolomics techniques.